Gland Pharma is one of the fastest growing generic injectable-focused companies by revenue in the United States from 2014 to 2019 as per IQVIA report. Company sells its products primarily under a B2B model which accounted for 97% of FY2020 revenues. Company exports to over 60 countries as of June 30, 2020, including the United States, Europe, Canada, Australia and the Rest of the world. The company has an extensive track record in complex injectable development, manufacturing and marketing.
Download Full Report
View Full Report in Browser 
